There are 2942 resources available
Access, availability, and uptake of combination therapies in Europe
Presenter: Tim Wilsdon
Session: MSD - New approaches, old barriers: Will cancer patients get access to the combinations and early treatments they need?
Resources:
Webcast
Welcome and Introduction
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Live Q&A - 15 September 2020 - 09:30-10:00
Presenter: Peter R. Galle
Session: Ipsen - The today and tomorrow of systemic treatment for HCC
Resources:
Webcast
I-O for upper GI cancers: Where are we today?
Presenter: Elizabeth Smyth
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Live Q&A - 18 September 2020 - 17:00-18:00
Presenter: Boris Hadaschik
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
The payer perspective: Utilising RWD to determine the value of drugs
Presenter: Oriol Solà-Morales
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Panel discussion
Presenter: George Demetri, Jorge Camarero, Oriol Solà-Morales, Renate Haidinger
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast
Welcome and Introduction
Presenter: James Larkin
Session: Bristol Myers Squibb - Harnessing the Potential of the Immune System: Clinical Insights From Utilizing CTLA-4 Within a Dual I-O Approach in aRCC
Resources:
Webcast
Uncommon EGFR mutations in NSCLC
Presenter: Zofia Piotrowska
Session: Janssen - Intrinsic and acquired resistance to EGFR TKIs: New therapies on the horizon
Resources:
Webcast
Live Q&A - 24 September 2020 - 17:00-17:30
Presenter: Eva Ciruelos
Session: F. Hoffmann-La Roche - Transforming patient care: Leveraging the latest clinical data in HER2-positive eBC
Resources:
Webcast